Anika Therapeutics, Inc. (ANIK)
21.31
-0.47
(-2.16%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
0.00 (0.00%)
After-Hours: 19:58
Anika Therapeutics Shareholders Equity (Quarterly) : 137.28M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 137.28M |
| March 31, 2026 | 133.90M |
| December 31, 2025 | 143.46M |
| September 30, 2025 | 146.80M |
| June 30, 2025 | 147.67M |
| March 31, 2025 | 148.40M |
| December 31, 2024 | 153.99M |
| September 30, 2024 | 179.86M |
| June 30, 2024 | 210.34M |
| March 31, 2024 | 208.54M |
| December 31, 2023 | 212.26M |
| September 30, 2023 | 270.49M |
| June 30, 2023 | 274.02M |
| March 31, 2023 | 277.59M |
| December 31, 2022 | 285.56M |
| September 30, 2022 | 284.94M |
| June 30, 2022 | 286.15M |
| March 31, 2022 | 285.79M |
| December 31, 2021 | 287.08M |
| September 30, 2021 | 290.06M |
| June 30, 2021 | 286.80M |
| March 31, 2021 | 276.66M |
| December 31, 2020 | 272.40M |
| September 30, 2020 | 284.45M |
| June 30, 2020 | 288.44M |
| Date | Value |
|---|---|
| March 31, 2020 | 293.69M |
| December 31, 2019 | 288.38M |
| September 30, 2019 | 281.68M |
| June 30, 2019 | 250.95M |
| March 31, 2019 | 269.07M |
| December 31, 2018 | 263.61M |
| September 30, 2018 | 255.26M |
| June 30, 2018 | 246.60M |
| March 31, 2018 | 263.77M |
| December 31, 2017 | 263.49M |
| September 30, 2017 | 253.29M |
| June 30, 2017 | 244.14M |
| March 31, 2017 | 230.03M |
| December 31, 2016 | 222.77M |
| September 30, 2016 | 214.54M |
| June 30, 2016 | 204.42M |
| March 31, 2016 | 195.37M |
| December 31, 2015 | 210.85M |
| September 30, 2015 | 199.75M |
| June 30, 2015 | 190.57M |
| March 31, 2015 | 181.82M |
| December 31, 2014 | 178.10M |
| September 30, 2014 | 169.70M |
| June 30, 2014 | 162.39M |
| March 31, 2014 | 156.57M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 323.86M |
| MiMedx Group, Inc. | 216.00M |
| ABVC BioPharma, Inc. | 10.29M |
| Enovis Corp. | 1.477B |
| Edwards Lifesciences Corp. | 10.62B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.47M |
| Total Liabilities (Quarterly) | 46.19M |
| Debt to Equity Ratio | 0.1839 |
| Current Ratio | 4.479 |
| Net Debt Paydown Yield | 0.02% |